EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PGI2 signaling metabolically reprograms CD4 Th2 cells and represses allergic airway inflammation

Weisong Zhou iD, Jian Zhang, Nowrin U Chowdhury, Allison E Norlander, Shinji Toki, Masako Abney, Mark Rusznak, Katherine N Gibson-Corley, Daniel P Cook, Dawn C Newcomb, Ray Stokes Peebles

The Journal of Immunology · 2025

DOI: 10.1093/jimmun/vkaf130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Weisong Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United St…. Hauptthemen laut MEDLINE: Th2 Cells, Epoprostenol, Hypersensitivity. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostaglandin I2 (PGI2) is a lipid mediator known to inhibit T helper 2 (Th2) immune responses and allergic inflammation, but its role in regulating Th2 cell metabolism remains underexplored. Using the Seahorse assay, we evaluated the effects of PGI2 signaling on Th2 cell glycolysis and mitochondrial respiration. Our results show that cicaprost, a stable PGI2 analog, significantly reduced basal, maximal, and spare glycolytic capacities in wild-type Th2 cells, while these effects are absent in Th2 cells lacking the PGI2 IP receptor (IP knockout [KO]). Cicaprost also impaired mitochondrial respiration and adenosine triphosphate production in wild-type Th2 cells, but not in IP KO cells, indicating that PGI2 signaling is essential for these metabolic changes. Further analysis revealed that cicaprost decreased glucose transporter 1 expression and glucose uptake and inhibited mitochondrial mass and membrane potential, suggesting that PGI2 signaling inhibits Th2 cell metabolism by reducing glucose availability and mitochondrial respiratory functions. Metabolomic profiling of cicaprost-treated Th2 cells showed dose-dependent changes, with 126 downregulated and 233 upregulated metabolites showing over 2-fold significant changes compared with vehicle-treated cells. Pathway analysis of these altered metabolites suggests a shift from catabolism to anabolism in cicaprost-treated Th2 cells. In vivo, CD4-specific conditional IP KO mice (CD4Cre+IPflox) exhibited exacerbated lung inflammation following exposure to Alternaria alternata extract, marked by increased IL-5 and IL-13 production, enhanced eosinophilia, and elevated mucus production. These findings establish a mechanistic link between PGI2-mediated immunoregulation and metabolic reprogramming, reinforcing its role as a key modulator of allergic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Th2 CellsEpoprostenolHypersensitivityAnimalsMiceSignal TransductionMice, KnockoutMitochondriaMice, Inbred C57BLInflammationGlycolysisReceptors, Epoprostenol

Stichwörter der Autor:innen

T cellsinflammationlungmouse

Substanzen

EpoprostenolcicaprostReceptors, Epoprostenol

Autor:innen und Institutionen

  • Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States.
  • Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Division of Comparative Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, United States.
  • Department of Internal Medicine, University of Iowa, Iowa City, IA, United States.

ORCID-Profile: Weisong Zhou

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service
  • NIGMS NIH HHS
  • BLRD VA
  • National Institutes of Health

Zitieren

APA

Zhou, W., Zhang, J., Chowdhury, N. U., Norlander, A. E., Toki, S., Abney, M., Rusznak, M., Gibson-Corley, K. N., Cook, D. P., Newcomb, D. C., & Peebles, R. S. (2025). PGI2 signaling metabolically reprograms CD4 Th2 cells and represses allergic airway inflammation. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf130

Vancouver

Zhou W, Zhang J, Chowdhury NU, Norlander AE, Toki S, Abney M, et al. PGI2 signaling metabolically reprograms CD4 Th2 cells and represses allergic airway inflammation. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf130

BibTeX
@article{Zhou2025,
  author = {Zhou, Weisong and Zhang, Jian and Chowdhury, Nowrin U and Norlander, Allison E and Toki, Shinji and Abney, Masako and Rusznak, Mark and Gibson-Corley, Katherine N and Cook, Daniel P and Newcomb, Dawn C and Peebles, Ray Stokes},
  title = {PGI2 signaling metabolically reprograms CD4 Th2 cells and represses allergic airway inflammation},
  journal = {The Journal of Immunology},
  year = {2025},
  doi = {10.1093/jimmun/vkaf130}
}
Kostenlos starten →